MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Director, Case CCC
NCRM Cancer Stem Cell Conference: Updated Program
Dear Cancer Center Members:
As a reminder, the Case Comprehensive Cancer Center and National Center for Regenerative Medicine (NCRM) are hosting the Cancer Stem Cell Conference (CSC 2014), August 17-20, 2014 at the Cleveland Convention Center.
This four-day conference has already attracted an impressive array of attendees; so far we have over 250 registrants from 15 countries and 25 states.
The program agenda has been carefully planned to include a wide breadth of topics that will appeal to a diverse audience, from those with a long-standing stem cell research background, to researchers who have a newfound interest in the field. The program agenda is organized around scientific session on Genetics, Brain Tumors, Tumor Microenvironment, Metabolism and Inflammation, Epithelial Tumors, Metastasis, DNA and Genomics, Therapeutic Resistance, Epigenetics and RNA, Development and Tumor Evolution.
In addition, I want to point out that the program faculty boasts an assembly of world-class experts, including Irving Weissman (Stanford University), Luis Parada (UT Southwestern), M. Celeste Simon (University of Pennsylvania), John Condeelis (Albert Einstein College of Medicine), and Bradley Bernstein (Massachusetts General Hospital), just to name a few.
I encourage you to view the updated program agenda, view the impressive group of presenters being brought together at this forum, and register to attend this inaugural Cancer Stem Cell Conference.
CASE CCC IN THE NEWS
The Pill Linked to Breast Cancer Risk
MedPage Today - Aug 1, 2014
Recent use of some oral contraceptives is associated with an increased risk of breast cancer, researchers reported...But the risk varied with formulation of the contraceptives; some types – notably those with low-dose estrogen – were not associated with cancer, Beaber and colleagues reported in the Aug. 1 issue of Cancer Research. Many women ask about oral contraceptives and breast cancer and the benefits and risks need to be clearly understood, commented Holly Pederson, MD, of the Cleveland Clinic.
CWRU Gets $1.6 Million Grant for Nursing Program to Increase Patient Participation in Clinical Cancer Trials
The Plain Dealer - Jul 30, 2014
The National Cancer Institute is giving Case Western Reserve University researchers $1.6 million over five years to develop and nationally test a program designed to help oncology nurses educate cancer patients about clinical trials. The researchers, from CWRU's School of Medicine and Frances Payne Bolton School of Nursing, will be testing two components: educational materials in the form of texts, and a web-based program called Oncology Nurse IMPACT. They will see how effective each is, and which has the most impact in increasing the number of qualified cancer patients who participate in clinical trials. "Patients have fears about trials and researchers in general," Barbara Daly, an oncology nursing professor at CWRU and clinical ethics director at University Hospitals Case Medical Center, told The Plain Dealer...To that end, Daly and Dr. Neal Meropol, chief of the division of hematology/oncology at UH and CWRU and associate director for clinical programs at UH Seidman Cancer Center, are leading a team of researchers who are developing a program to educate nurses on how to approach patients and discuss clinical trials as a routine treatment option...
RESEARCH HIGHLIGHTS/MEMBER NEWS
CORRECTION: Ahluwalia Elected As Chair of ASCO Committee
Dr. Manmeet Ahluwalia, Associate Director of Clinical Trials, Operations and Section Head of NeuroOncology Outcomes in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center of the Cleveland Clinic Neurological Institute, and member of the Case Comprehensive Cancer Center, has been elected as Chair of the ASCO Cancer Education Committee on the Central Nervous System Tumors Track.
NEWS FROM THE NCI
NCI Community Oncology Research Program (NCORP)
The National Cancer Institute (NCI) is pleased to announce the official launch of the new NCI Community Oncology Research Program (NCORP). NCORP is a national network of investigators, cancer care providers, academic institutions, and other organizations that provide care to diverse populations in community-based healthcare practices across the United States. This effort is a collaboration between NCI's Divisions of Cancer Prevention, Cancer Control and Population Sciences, Cancer Treatment and Diagnosis, and Center to Reduce Cancer Health Disparities.
NCORP will design and conduct trials to improve cancer prevention, cancer control, screening, and post-treatment management. Additionally, a new focus for NCI community-based research will be care delivery and comparative effectiveness research that will focus on the factors that affect access to and quality of care in the community. NCORP is particularly committed to increasing access to NCI research for minority, rural, and other underserved patient populations.
NCORP replaces two previous NCI community-based clinical research programs: the NCI Community Clinical Oncology Program (CCOP), made up of the Community Clinical Oncology Programs, Minority-Based Clinical Oncology Programs, and Research Bases, and the NCI Community Cancer Centers Program (NCCCP).
PILOT PROJECT GRANTS: American Cancer Society IRG Awards
The Case Comprehensive Cancer Center, with funds from its American Cancer Society Institutional Research Grant (IRG), will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but cannot currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
LOI Deadline: August 15
Application Deadline: August 27
James S. McDonnell Foundation
The James S. McDonnell Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas:
- Studying Complex Systems
- Understanding Human Cognition
- Mathematical & Complex Systems Approaches for Brain Cancer
MARK YOUR CALENDARS
SOM Institutional Scientific Core Facility Retreat
The Second Annual SOM Institutional Scientific Core Facility Retreat is scheduled for August 25. Retreat participation is by invitation only and is primarily for Core Facility Directors and Managers, as well as Administrative/Clerical Staff. However, there will be limited additional seating available. If you would like to attend, please follow this link to request an invitation.
PREVIOUSLY ANNOUNCED OPPORTUNITIES
NIH BULLETIN – Notices and Funding Opportunities
Notice of Modification of Allowable Budgets for Data Deposition in PA-14-154 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R43/R44)" (NOT-GM-14-123)
Notice of Modification of Allowable Budgets for Data Deposition in PA-14-156 "Extended Development, Hardening and Dissemination of Technologies in Biomedical Computing, Informatics and Big Data Science (R01)" (NOT-GM-14-125)
Notice of Modification of Allowable Budgets for Data Deposition in PA-14-157 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R41/R42)" (NOT-GM-14-126)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to Gillian Irwin at email@example.com.